Dermatology Times Newsletter

To view this email as a web page, click here.

Immune modulators offer promising outcomes

Immune system modulators are changing the ways in which dermatologists treat inflammatory skin diseases. But how best to use these medications and for which skin diseases isn’t always clear.

A new more powerful molecule as psoriasis target

Immune cell derivative itaconate may combat psoriasis and other autoimmune diseases, shows a study in Nature.

Shingles vaccine can last three years, study shows

Immune responses to the latest shingles vaccine (Shingrix) lasts for at least three years after vaccination. The robust immune responses develop and persist in all age groups, according to a recent study in The Journal of Infectious Diseases.

JOB OPPORTUNITIES

AZ - Integrated Dermatology

CO - Dermatology Specialists of Boulder

CO - Leavitt Management Group

CT - Integrated Dermatology

FL - Integrated Dermatology

FL - Leavitt Management Group

GA - Leavitt Management Group

IL - Integrated Dermatology

MA - Integrated Dermatology

MD - Integrated Dermatology

MI - Leavitt Management Group

National - Integrated Dermatology

NC - Integrated Dermatology

NJ - Integrated Dermatology

NY - Integrated Dermatology

OR - Cynthia Dreyer MD

PA - Leavitt Management Group

PA - Integrated Dermatology

RI - Leavitt Management Group

TN - Integrated Dermatology

TX - Company Confidential

VA - Integrated Dermatology

WA - Integrated Dermatology

WY - Leavitt Management Group

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

CONNECT